# Beam Therapeutics Inc.: Form 10-Q for the period ended Sep 30, 2020

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: 10-Q
- Filed: 2020-11-10
- Accepted by EDGAR: Nov 10, 2020, 06:49 ET
- Period: 2020-09-30
- Accession: 0001564590-20-052723
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000156459020052723/beam-10q_20200930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000156459020052723/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2020-07-01 to 2020-09-30 | $29.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2020-01-01 to 2020-09-30 | $70.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | −$37.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | −$92.0m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$34.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$99.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | −$71.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $8.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-09-30 | $137.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $208.7m | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $278.3m | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $47.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $78.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-09-30 | $200.1m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000156459020052723/beam-10q_20200930.htm

Filed Nov 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-052723. Last ingested by Listed: Nov 14, 2026, 12:58 ET. No prices; not investment advice.
